Xponance, Inc. Reata Pharmaceuticals Inc Transaction History

Xponance, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$100.0 - $143.02 $150,300 - $214,959	-1,503 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$78.27 - $151.29 $78,270 - $151,290	-1,000 Reduced 39.95%	1,503 $213,000
Q1 2021 May 10, 2021	BUY	$94.25 - $132.81 $25,636 - $36,124	272 Added 12.19%	2,503 $250,000
Q4 2020 Feb 11, 2021	SELL	$102.03 - $184.62 $6,325 - $11,446	-62 Reduced 2.7%	2,231 $276,000
Q3 2020 Oct 26, 2020	BUY	$93.53 - $163.34 $6,079 - $10,617	65 Added 2.92%	2,293 $223,000
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $281,396 - $393,375	2,228 New	2,228 $348,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.